NCT06732388 2026-03-18
Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
National Cancer Institute (NCI)
Phase 2 Not yet recruiting
Clinical Trials
15 trialsNCT07247565 2025-11-25
Comparative Study Between Conventional Radiofrequency Ablation vs Chemical Neurolysis of Ganglion Impar for Treatment of Chronic Non Cancer Related Coccydynia
Ain Shams University
Phase NA Active not recruiting
NCT01153035 2025-11-10
ABLATE
University of Arkansas
Phase NA Active not recruiting
NCT02163525 2025-09-30
Post Market TRUST - U.S.A. Study
Acessa Health, Inc.
Phase NA Completed
NCT04389216 2025-09-15
RFA
Hospital Universitari de Bellvitge
Phase NA Completed
NCT00712712 2025-08-29
MEDOR
Institut Bergonié
Phase 2 Completed
NCT07095803 2025-07-31
Ivonescimab (PD-1/VEGF Bispecific Antibody) Plus Radiofrequency Ablation for Multiple Advanced Tumors After PD-1 Therapy Failure
Fudan University
Phase 2 Not yet recruiting
NCT05142904 2025-07-17
RABITO
Rijnstate Hospital
Phase 3 Terminated
NCT04520932 2025-05-25
RFANET
Institut Paoli-Calmettes
Phase NA Recruiting
NCT04522570 2025-04-30
Thermal Ablation of Cervical Metastases From Thyroid Carcinoma
Instituto do Cancer do Estado de São Paulo
Phase NA Active not recruiting
NCT06929650 2025-04-16
The Safety and Feasibility of Radiofrequency Ablation to Treat Low-risk Thyroid Cancer
University Health Network, Toronto
Phase NA Recruiting
NCT01792934 2025-04-15
ORCHESTRA
Radboud University Medical Center
Phase NA Active not recruiting
NCT04062721 2025-04-06
LICoRN-01
Assistance Publique - Hôpitaux de Paris
Phase 1 Not yet recruiting
NCT05003856 2025-04-02
Radiofrequency Ablation for the Treatment of Benign or Low Risk Thyroid Nodule
M.D. Anderson Cancer Center
Phase NA Terminated
NCT05551299 2025-03-27
CARP
University of Leipzig
Phase 4 Recruiting